2210010N04Rik Activators
2210010N04Rik activators encompass a series of chemical compounds that indirectly enhance the functional activity of 2210010N04Rik through precise modulation of various signaling pathways. The diterpenoid Forskolin, through its action on adenylate cyclase, raises intracellular cAMP levels, thereby indirectly enhancing 2210010N04Rik's activity by promoting PKA-mediated phosphorylation events that may affect 2210010N04Rik directly or its interacting substrates. Similarly, the phosphodiesterase inhibitors IBMX and Sildenafil prevent the breakdown of cyclic nucleotides, cAMP and cGMP respectively, leading to an accumulation that activates PKA and PKG, which may subsequently phosphorylate targets influencing 2210010N04Rik's functional state. PMA, by activating PKC, and the calcium ionophores Ionomycin and A23187, by elevating intracellular calcium, activate different protein kinases, potentially culminating in the phosphorylation and thus activation of 2210010N04Rik. Furthermore, the kinase inhibitor Epigallocatechin gallate (EGCG) may enhance 2210010N04Rik's activity by inhibiting negative regulatory kinases, thereby relieving 2210010N04Rik from inhibitory pressure.
The PI3K inhibitor LY294002, by altering PI3K/AKT/mTOR pathway dynamics, along with PD98059 and SB203580, which inhibit MEK and p38 MAPK respectively, may facilitate compensatory signaling that leads to the activation of 2210010N04Rik through non-canonical routes. These inhibitors could shift signaling equilibriums to favor pathways that activate 2210010N04Rik, either by relieving it from competitive inhibition or by allowing cross-talk with parallel signaling cascades. Zinc chloride, by modulating ion channels and receptors, could also lead to changes in cellular signaling conducive to the activation of 2210010N04Rik. Lastly, Dibutyryl-cAMP, as a synthetic analog of cAMP, can permeate cell membranes and directly activate cAMP-dependent pathways, reinforcing the activation of 2210010N04Rik through cAMP-responsive elements.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Isobutylmethylxanthine (IBMX) is a non-selective inhibitor of phosphodiesterases, enzymes responsible for breaking down cAMP. By preventing cAMP degradation, IBMX indirectly increases the activity of PKA, which could result in enhanced phosphorylation and activation of 2210010N04Rik. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) is a potent activator of protein kinase C (PKC) which participates in a multitude of cellular processes. Activation of PKC can lead to downstream signaling events that enhance the functional activity of 2210010N04Rik through phosphorylation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentrations. The rise in calcium levels can activate calcium-dependent protein kinases, which may then phosphorylate 2210010N04Rik or associated proteins, thereby enhancing its activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore that raises intracellular calcium levels, similar to Ionomycin. This elevation in calcium can activate calmodulin and calmodulin-dependent kinases, potentially leading to increased activity of 2210010N04Rik through downstream signaling effects. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate (EGCG) is known to modulate various cell signaling pathways, including those involving kinases. By inhibiting certain kinases, EGCG could reduce negative regulation or competition, potentially enhancing signaling pathways that activate 2210010N04Rik. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that changes the dynamics of the PI3K/AKT/mTOR pathway. By inhibiting PI3K, it could indirectly influence pathways that lead to the activation of 2210010N04Rik, possibly through changes in phosphorylation patterns of downstream proteins. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that acts upstream of ERK in the MAPK pathway. Inhibition of MEK could lead to compensatory activation of parallel pathways, potentially including those that activate 2210010N04Rik through alternative signaling mechanisms. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a selective inhibitor of p38 MAPK. By inhibiting p38 MAPK, it could lead to redirection of signaling towards alternative pathways that upregulate the activity of 2210010N04Rik, by relieving competitive inhibition or through cross-talk between signaling cascades. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc chloride can function as a signaling molecule and modulate a variety of ion channels and receptors. The resultant changes in cellular ion homeostasis and receptor activity may indirectly enhance the activity of 2210010N04Rik via alteration of cellular signaling pathways. | ||||||